Rationalizing the introduction and use of pharmaceutical products: The role of managed entry agreements in Central and Eastern European countries.

•In countries in CEE the main role of MEAs and other related policies is to limit the budget impact.•Uncertainty about outcomes and appropriate utilization seem to be of lower priority in CEE’s.•Finance-based MEAs are used by all CEE countries reviewed.•There is limited transparency on the details of MEAs in the CEE countries reviewed.